Erythema Nodosum Leprosum: Reactional Leprosy

Seminars in Cutaneous Medicine and Surgery

Volumn 26, Issue 2, 2007, Pages 126-130

  Cuevas, Jesús ^a   Rodríguez Peralto, José Luis ^b   Carrillo, Rosario ^c   Contreras, Félix ^d  

^a HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

erythema nodosum leprosum; erythema polymorphous like reaction; leprosy; leprosy reaction; Lucio's phenomenon

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; PENTOXIFYLLINE; THALIDOMIDE;

CELLULAR IMMUNITY; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DRUG MECHANISM; ERYTHEMA NODOSUM LEPROSUM; ERYTHEMA POLYMORPHOUS LIKE REACTION; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; LEPROMATOUS LEPROSY; LUCIO PHENOMENON; MYCOBACTERIUM LEPRAE; NEUROPATHY; NONHUMAN; REVIEW; SIDE EFFECT; TERATOGENESIS; TUBERCULOID LEPROSY;

DIAGNOSIS, DIFFERENTIAL; ERYTHEMA NODOSUM; HUMANS; LEPROSY, LEPROMATOUS;

EID: 34249736871     PISSN: 10855629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sder.2007.02.010     Document Type: Review

References (24)

1. Sehgal V.N., Srivastava G., and Sundharam J.A. Immunology of reactions in leprosy. Current status. Int J Dermatol 27 (1988) 157-162
2. Rea T.H., and Modlin R.L. Immunopathology of leprosy skin lesions. Semin Dermatol 10 (1991) 188-193
3. Wemambu S.N.C., Turck J.L., Waters M.F.R., et al. ENL. A clinical manifestation of the Arthus phenomenon. Lancet 2 (1969) 933-935
4. Vieira L.M., Sampaio E.P., Nery J.A., et al. Immunological status of ENL (erythema nodosum leprosum) patients: Its relationship to bacterial load and levels of circulating IL-2R. Rev Inst Med Trop Sao Paulo 38 (1996) 103-111
5. Murphy G.F., Sánchez N.P., Flynn T.C., et al. Erythema nodosum leprosum: Nature and extent of the cutaneous microvascular alterations. J Am Acad Dermatol 14 (1986) 59-69
6. Mathur N.K., Mangal H.N., Mathur D., et al. Langerhans cell and leprosy. Lepr India 55 (1983) 22-28
7. Cuevas Santos J: Estudio inmunohistoquímico básico de las células del sistema monocito-macrófago, en el espectro inmunopatológico de la lepra. Tesis Doctoral ed. Alcalá de Henares, España: Universidad de Alcalá. Facultad de Medicina, 1996
8. Cuevas-Santos J., Contreras F., and McNutt N.S. Multibacillary leprosy: Lesions with macrophages positive for S100 protein and dendritic cells positive for Factor 13a. J Cutan Pathol 25 (1998) 530-537
9. Bjune G., and Barnetson R.S. Plasma factors in delayed type hypersensitivity augmentation of lymphocyte responses in borderline leprosy reactions. Clin Exp Immunol 26 (1976) 397-402
10. Vazquez-Botet M., and Sánchez J.L. Erythema nodosum leprosum. Int J Dermatol 26 (1987) 436-437
11. Rea T.H., and Ridley D.S. Lucio's phenomenon: A comparative histological study. Int J Lepr 47 (1979) 161-166
12. Pocaterra L., Jain S., Reddy R., et al. Clinical course of erythema nodosum leprosum: An 11-year cohort study in Hyderabad, India. Am J Trop Med Hyg 74 (2006) 868-879
13. Manandhar R., LeMaster J.W., and Roche P.W. Risk factors for erythema nodosum leprosum. Int J Lepr Other Mycobact Dis 67 (1999) 270-278
14. Ridley M.J., and Ridley D.S. The immunopathology of erythema nodosum leprosum: The role of extravascular complexes. Lepr Rev 54 (1983) 95-107
15. Lucio R., and Alvarado I. Opúsculo sobre el Mal de San Lázaro o Elefantiasis de los Griegos. (1851). Dermatol Rev Mex 22 (1978) 93-101
16. Latapí F., and Zamora A.C. The "spotted" leprosy of Lucio. Int J Lepr 16 (1948) 421-429
17. Quismorio F.P., Rea T., Chandors, et al. Lucio's phenomenon: an immune complex deposition syndrome in lepromatous leprosy. Clin Immunol Immunopathol 9 (1978) 184-193
18. Magaña M. Eritema necrosante o fenómeno de Lucio Vasculitis?. De qué tipo, de qué vasos, qué mecanismo?. Acta Dermatol Dermatopatol 6 (2006) 5-7
19. Deng L., Ding W., and Granstein R.D. Thalidomide inhibits tumor necrosis factor-alpha production and antigen presentation by Langerhans cells. J Invest Dermatol 121 (2003) 1060-1065
20. Wu J.J., Huang D.B., Pang K.R., et al. Thalidomide: Dermatological indications, mechanisms of action and side-effects. Br J Dermatol 153 (2005) 254-273
21. Teo S.K., Resztak K.E., Scheffler M.A., et al. Thalidomide in the treatment of leprosy. Microbes Infect 4 (2002) 1193-1202
22. Girdhar A., Chakma J.K., and Girdhar B.K. Pulsed corticosteroid therapy in patients with chronic recurrent ENL: A pilot study. Indian J Lepr 74 (2002) 233-236
23. Sampaio-EP, Moraes-MO, Nery JA, et al: Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL). Clin Exp Immunol 111:300-308, 1998
24. De Carsalade G.Y., Achirafi A., and Flageul B. Pentoxifylline in the treatment of erythema nodosum leprosum: Results of an open study. Acta Leprol 12 (2003) 117-122